BioAegis Therapeutics Unveils Upcoming Clinical Study of Gelsolin, an Immune Regulator, as a Treatment for Patients with Acute Respiratory Distress Syndrome (ARDS)
27 févr. 2024 15h52 HE
|
BioAegis Therapeutics
BioAegis announces global Phase 2 study of its inflammation regulator protein, gelsolin, for the treatment of Acute Respiratory Distress Syndrome (ARDS).
Purple Biotech Presents Data of its Phase 1 Head & Neck Cancer of NT219 in combination with Cetuximab at ESMO TAT Congress 2024
27 févr. 2024 07h00 HE
|
Purple Biotech Ltd.
NT219 was well tolerated Anti-tumor activity at relevant higher dose levels observed with 29% Objective Response Rate (ORR) and 71% Disease Control Rate (DCR) REHOVOT, Israel, Feb. 27, 2024...
Turnstone Biologics to Participate in Upcoming Investor Conferences
21 févr. 2024 06h00 HE
|
Turnstone Biologics Corp.
Turnstone to present and participate in TD Cowen 44th Annual Global Health Care Conference and Leerink Partners Global Biopharma Conference 2024.
China Oncology Drugs Market Report, 2023 and 2024-2028 - Cancer Prevention Takes Center Stage in China's National Health Agenda
19 févr. 2024 07h48 HE
|
Research and Markets
Dublin, Feb. 19, 2024 (GLOBE NEWSWIRE) -- The "China Oncology Drugs Market, Size, Forecast 2024-2028, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has been...
Vaccinex, Inc. Announces Reverse Stock Split
15 févr. 2024 08h00 HE
|
Vaccinex, Inc.
ROCHESTER, N.Y., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc., (NASDAQ: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative disease...
Allergy Immunotherapy Soars: Anticipating a $2.69 Billion Market by 2028 with an Impressive CAGR of 8.12%
05 févr. 2024 04h41 HE
|
Research and Markets
Dublin, Feb. 05, 2024 (GLOBE NEWSWIRE) -- The "Global Allergy Immunotherapy Market (2023-2028) by Type, Application and Distribution Channel, and Geography, Competitive Analysis, Impact of Covid-19,...
Global Cancer Immunotherapy Market to Reach $188.11 Billion by 2030, Propelled by Innovative Treatments and Rising Incidence Rates
05 févr. 2024 04h21 HE
|
Research and Markets
Dublin, Feb. 05, 2024 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report...
Global Next Generation Immunotherapies Market Forecast Report to 2028, by Drug Class, Route of Administration, Distribution Channel and Geography
01 févr. 2024 10h27 HE
|
Research and Markets
Dublin, Feb. 01, 2024 (GLOBE NEWSWIRE) -- The "Global Next Generation Immunotherapies Market (2023-2028) by Drug Class, Route of Administration, Distribution Channel, and Geography, Competitive...
Gallbladder Cancer Therapeutics Market to Witness Upsurge; Forecasted Growth at 6.63% CAGR by 2028 with Emerging Trends in Immunotherapy and Genomic Testing
01 févr. 2024 10h22 HE
|
Research and Markets
Dublin, Feb. 01, 2024 (GLOBE NEWSWIRE) -- The "Global Gallbladder Cancer Therapeutics Market 2024-2028" report has been added to ResearchAndMarkets.com's offering. The gallbladder cancer...
Global Injectable Cytotoxic Drugs Research Report 2024: Cyclophosphamide Approval Boosts Outlook - Market to Reach $33.78 Billion by 2034 from $18.63 Billion in 2023
31 janv. 2024 09h46 HE
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Global Injectable Cytotoxic Drugs Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering.The global...